Purdue Pharma LP and its owners are a step closer to getting the Second Circuit to hear their appeal of a judge’s decision overturning the opioid maker’s multibillion-dollar bankruptcy plan.
U.S. District Judge Colleen McMahon, who Friday certified the mid-case appeal, conditioned her order on the appeal being filed by Jan. 17. The parties must also ask the U.S. Court of Appeals for the Second Circuit to hear the case on an expedited basis due to the urgent opioid crisis and the case’s importance, she said.
The appeal, if taken by the Second Circuit, could turn the massive, controversial bankruptcy ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.